toviaz 4 mg
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
toviaz 8 mg
pfizer pharmaceuticals israel ltd - fesoterodine fumarate - tablets sustained release - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.
toviaz
pfizer europe ma eeig - fesoterodine fumarate - urinary bladder, overactive - urologicals - treatment of the symptoms (increased urinary frequency and / or urgency and / or urgency incontinence) that may occur in patients with overactive-bladder syndrome.
toviaz 4mg modified-release tablets
pfizer ltd - fesoterodine fumarate - modified-release tablet - 4mg
toviaz 8mg modified-release tablets
pfizer ltd - fesoterodine fumarate - modified-release tablet - 8mg
fesoterodine clonmel 4 mg prolonged-release tablets
clonmel healthcare ltd - fesoterodine fumarate - prolonged-release tablet - 4 milligram(s) - fesoterodine
fesoterodine clonmel 8 mg prolonged-release tablets
clonmel healthcare ltd - fesoterodine fumarate - prolonged-release tablet - 8 milligram(s) - fesoterodine
fesoterodine accord 8 mg prolonged-release tablets
accord healthcare ireland ltd. - fesoterodine fumarate - prolonged-release tablet - 8 milligram(s) - fesoterodine
fesoterodine aristo 4 mg prolonged-release tablets
aristo pharma gmbh - fesoterodine fumarate - prolonged-release tablet - 4 milligram(s) - fesoterodine
fesoterodine aristo 8 mg prolonged-release tablets
aristo pharma gmbh - fesoterodine fumarate - prolonged-release tablet - 8 milligram(s) - fesoterodine